title: Annual Combined Mammography and Tomosynthesis Screening: Is It Really Cost-Effective?
abstract: Examining the comparative effectiveness of adding tomosynthesis to mammography screening in the United States would help key stakeholders, including physicians and policy makers, guide shared decision-making and recommendations for routine breast cancer screening.
  
  
  
  More robust data from U.S.-based longitudinal observational studies, clinical trials, or both are needed, along with the use of validated microsimulation models, before clinical- and cost-effectiveness of tomosynthesis screening versus mammography screening can be fully characterized.
authors.affiliation: 1 Department of Radiology, University of Washington School of Medicine, 825 Eastlake Ave E., G3-200, Seattle, WA 98109-1023.|2 Department of Health Services, University of Washington School of Public Health, Seattle, WA.|3 Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
authors.forename: Christoph I
authors.initials: CI
authors.lastname: Lee
authors.affiliation: 1 Department of Radiology, University of Washington School of Medicine, 825 Eastlake Ave E., G3-200, Seattle, WA 98109-1023.|3 Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
authors.forename: Janie M
authors.initials: JM
authors.lastname: Lee
authors.affiliation: 4 Department of Medicine and The Dartmouth Institute for Health Policy & Clinical Practice, Norris Cotton Cancer Center, Geisel School of Medicine, Lebanon, NH.
authors.forename: Anna N A
authors.initials: AN
authors.lastname: Tosteson
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis; D003362:Cost-Benefit Analysis; D055088:Early Detection of Cancer; D006801:Humans; D008327:Mammography; D008403:Mass Screening; D008962:Models, Theoretical
keywords: cost-effectiveness; mammography; screening; tomosynthesis